488 OriA631-B: a first-in class CD39/PD-L1 bispecific antibody unleashing enhanced cancer immunotherapy
oleh: Yuchen Zhang, Huajing Wang, Xian-Yang Li, Xiaowen He, Xiaopei Li, Qi Deng
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.